I Jesse Treu
Affiliations
- Director at Aldeyra Therapeutics Inc. (ALDX), 2020-06-11
- Large Shareholder at Obalon Therapeutics Inc (OBLN), 2019-08-08
- Large Shareholder at Alliqua Biomedical Inc. (ADYX), 2019-05-13
- Director at Veracyte Inc. (VCYT), 2019-03-04
- Large Shareholder at Bionano Genomics Inc (BNGO), 2018-08-27
- Large Shareholder at Dicerna Pharmaceuticals Inc (DRNA), 2017-12-20
- Large Shareholder at Ocera Therapeutics Inc. (OCRX), 2017-12-13
- Large Shareholder, Director at Tandem Diabetes Care Inc (TNDM), 2016-11-17
- Large Shareholder at Tobira Therapeutics Inc. (TBRA), 2016-11-04
- Large Shareholder at Colucid Pharmaceuticals Inc. (CLCD), 2016-09-13
- Large Shareholder at Evoke Pharma Inc (EVOK), 2016-05-27
- Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-08
- Large Shareholder at Glaukos Corp (GKOS), 2015-07-01
- Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-13
- Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-03-24
- Large Shareholder at Neothetics Inc. (NEOT), 2014-12-10
- Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-11-18
- Large Shareholder at Atara Biotherapeutics Inc. (ATRA), 2014-10-21
- Large Shareholder at Otonomy Inc. (OTIC), 2014-08-18
- Large Shareholder at Marinus Pharmaceuticals Inc (MRNS), 2014-08-07
- Large Shareholder at Cadence Pharmaceuticals Inc (CADX), 2014-03-21
- Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
- Large Shareholder at Alimera Sciences Inc (ALIM), 2014-01-17
- Large Shareholder at Clovis Oncology Inc. (CLVS), 2013-06-05
- Large Shareholder at Achillion Pharmaceuticals Inc (ACHN), 2013-01-18
- Large Shareholder at Celator Pharmaceuticals Inc (NONE), 2013-01-15
- Large Shareholder at Reva Medical Inc. (RVA), 2012-03-27
- Large Shareholder at Orexigen Therapeutics Inc. (OREX), 2011-12-22
- Large Shareholder at Zogenix Inc. (ZGNX), 2011-09-20
- Director at Somaxon Pharmaceuticals Inc. (SOMX), 2010-06-11
- Large Shareholder at Transcept Pharmaceuticals Inc (NOVC), 2009-01-30
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| RGDO | $4.00 | 750,000 | Large Shareholder, Director | 2,571,117 | 2013-08-27 | Filing | |
| OCRX | $6.03 | 331,873 | Large Shareholder | 1,857,036 | 2013-07-15 | Filing | |
| OCRX | $6.03 | 7,333 | Large Shareholder | 7,333 | 2013-07-15 | Filing | |
| OCRX | $6.03 | 988,285 | Large Shareholder | 988,285 | 2013-07-15 | Filing | |
| OCRX | $6.03 | 331,873 | Large Shareholder | 1,897,336 | 2013-07-15 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| ALDX | $10.01 | 445 | Director | 8,763 | 2019-03-26 | Filing | |
| ALDX | $10.01 | 96,298 | Director | 1,877,091 | 2019-03-26 | Filing | |
| VCYT | $20.21 | 12,193 | Director | 0 | 2019-03-04 | Filing | |
| VCYT | $20.21 | 414,958 | Director | 1,231,647 | 2019-03-04 | Filing | |
| VCYT | $20.45 | 2,023 | Director | 12,193 | 2019-03-01 | Filing |